Loading...

Apollo Hospitals Enterprise

NSEI:APOLLOHOSP
Snowflake Description

Reasonable growth potential average dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
APOLLOHOSP
NSEI
₹160B
Market Cap
  1. Home
  2. IN
  3. Healthcare
Company description

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The last earnings update was 157 days ago. More info.


Add to Portfolio Compare Print
APOLLOHOSP Share Price and Events
7 Day Returns
-8.4%
NSEI:APOLLOHOSP
-5.6%
IN Healthcare
-3.1%
IN Market
1 Year Returns
0.9%
NSEI:APOLLOHOSP
-14.7%
IN Healthcare
-9.2%
IN Market
APOLLOHOSP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Apollo Hospitals Enterprise (APOLLOHOSP) -8.4% -14.5% -6.6% 0.9% -19.3% 28%
IN Healthcare -5.6% -7.2% -5% -14.7% -12.9% 36.3%
IN Market -3.1% -3.8% -2.9% -9.2% 43.1% 83.1%
1 Year Return vs Industry and Market
  • APOLLOHOSP outperformed the Healthcare industry which returned -14.7% over the past year.
  • APOLLOHOSP outperformed the Market in India which returned -9.2% over the past year.
Price Volatility
APOLLOHOSP
Industry
5yr Volatility vs Market

Value

 Is Apollo Hospitals Enterprise undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Apollo Hospitals Enterprise to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Apollo Hospitals Enterprise.

NSEI:APOLLOHOSP Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 17 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 13.5%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NSEI:APOLLOHOSP
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 7.5%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.46
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.461 (1 + (1- 35%) (21.4%))
0.525
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.8 * 7.45%)
13.51%

Discounted Cash Flow Calculation for NSEI:APOLLOHOSP using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Apollo Hospitals Enterprise is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

NSEI:APOLLOHOSP DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (INR, Millions) 5,414.80 5,946.86 6,940.67 8,021.85 9,271.46
Source Analyst x5 Analyst x7 Analyst x6 Est @ 15.58% Est @ 15.58%
Present Value
Discounted (@ 13.51%)
4,770.33 4,615.51 4,745.68 4,832.13 4,920.14
Present value of next 5 years cash flows ₹23,883.79
NSEI:APOLLOHOSP DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= ₹9,271.46 × (1 + 7.55%) ÷ (13.51% – 7.55%)
₹167,306.37
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= ₹167,306.37 ÷ (1 + 13.51%)5
₹88,785.46
NSEI:APOLLOHOSP Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= ₹23,883.79 + ₹88,785.46
₹112,669.25
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹112,669.25 / 139.13
₹809.84
NSEI:APOLLOHOSP Discount to Share Price
Calculation Result
Value per share (INR) From above. ₹809.84
Current discount Discount to share price of ₹1,152.35
= -1 x (₹1,152.35 - ₹809.84) / ₹809.84
-42.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Apollo Hospitals Enterprise is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Apollo Hospitals Enterprise's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Apollo Hospitals Enterprise's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NSEI:APOLLOHOSP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-03-31) in INR ₹8.44
NSEI:APOLLOHOSP Share Price ** NSEI (2019-02-14) in INR ₹1152.35
India Healthcare Industry PE Ratio Median Figure of 24 Publicly-Listed Healthcare Companies 28.08x
India Market PE Ratio Median Figure of 2,734 Publicly-Listed Companies 15.39x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Apollo Hospitals Enterprise.

NSEI:APOLLOHOSP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NSEI:APOLLOHOSP Share Price ÷ EPS (both in INR)

= 1152.35 ÷ 8.44

136.54x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Apollo Hospitals Enterprise is overvalued based on earnings compared to the IN Healthcare industry average.
  • Apollo Hospitals Enterprise is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does Apollo Hospitals Enterprise's expected growth come at a high price?
Raw Data
NSEI:APOLLOHOSP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 136.54x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts
43.6%per year
Asia Healthcare Industry PEG Ratio Median Figure of 13 Publicly-Listed Healthcare Companies 1.83x
India Market PEG Ratio Median Figure of 608 Publicly-Listed Companies 1.1x

*Line of best fit is calculated by linear regression .

NSEI:APOLLOHOSP PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 136.54x ÷ 43.6%

3.13x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Apollo Hospitals Enterprise is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Apollo Hospitals Enterprise's assets?
Raw Data
NSEI:APOLLOHOSP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-03-31) in INR ₹233.71
NSEI:APOLLOHOSP Share Price * NSEI (2019-02-14) in INR ₹1152.35
India Healthcare Industry PB Ratio Median Figure of 32 Publicly-Listed Healthcare Companies 1.9x
India Market PB Ratio Median Figure of 3,588 Publicly-Listed Companies 1.06x
NSEI:APOLLOHOSP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NSEI:APOLLOHOSP Share Price ÷ Book Value per Share (both in INR)

= 1152.35 ÷ 233.71

4.93x

* Primary Listing of Apollo Hospitals Enterprise.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Apollo Hospitals Enterprise is overvalued based on assets compared to the IN Healthcare industry average.
X
Value checks
We assess Apollo Hospitals Enterprise's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Apollo Hospitals Enterprise has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Apollo Hospitals Enterprise expected to perform in the next 1 to 3 years based on estimates from 17 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
43.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Apollo Hospitals Enterprise expected to grow at an attractive rate?
  • Apollo Hospitals Enterprise's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Apollo Hospitals Enterprise's earnings growth is expected to exceed the India market average.
  • Apollo Hospitals Enterprise's revenue growth is expected to exceed the India market average.
Annual Growth Rates Comparison
Raw Data
NSEI:APOLLOHOSP Future Growth Rates Data Sources
Data Point Source Value (per year)
NSEI:APOLLOHOSP Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts 43.6%
NSEI:APOLLOHOSP Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 17 Analysts 12.3%
India Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 44.2%
India Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 13%
India Market Earnings Growth Rate Market Cap Weighted Average 18.4%
India Market Revenue Growth Rate Market Cap Weighted Average 11.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NSEI:APOLLOHOSP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (10 months ago) See Below
Future Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NSEI:APOLLOHOSP Future Estimates Data
Date (Data in INR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-03-31 210,000 1
2022-03-31 182,000 1
2021-03-31 121,959 10,556 5,619 16
2020-03-31 107,768 9,270 4,166 17
2019-03-31 95,032 5,110 2,663 17
NSEI:APOLLOHOSP Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2018-03-31 82,435 5,370 1,174
2017-03-31 72,557 6,226 2,210
2016-03-31 62,147 5,972 2,364

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Apollo Hospitals Enterprise's earnings are expected to grow significantly at over 20% yearly.
  • Apollo Hospitals Enterprise's revenue is expected to grow by 12.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NSEI:APOLLOHOSP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (10 months ago) See Below
Future Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below

All data from Apollo Hospitals Enterprise Company Filings, last reported 10 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:APOLLOHOSP Future Estimates Data
Date (Data in INR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-03-31
2022-03-31
2021-03-31 41.02 48.43 26.60 10.00
2020-03-31 29.89 38.80 21.70 11.00
2019-03-31 20.34 23.30 17.00 11.00
NSEI:APOLLOHOSP Past Financials Data
Date (Data in INR Millions) EPS *
2018-03-31 8.44
2017-03-31 15.88
2016-03-31 16.99

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Apollo Hospitals Enterprise is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Apollo Hospitals Enterprise's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Apollo Hospitals Enterprise has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Apollo Hospitals Enterprise performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Apollo Hospitals Enterprise's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Apollo Hospitals Enterprise's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Apollo Hospitals Enterprise's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Apollo Hospitals Enterprise's 1-year earnings growth is negative, it can't be compared to the IN Healthcare industry average.
Earnings and Revenue History
Apollo Hospitals Enterprise's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Apollo Hospitals Enterprise Company Filings, last reported 10 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:APOLLOHOSP Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-03-31 82,434.68 1,174.18 5,180.92
2017-03-31 72,557.03 2,209.90 4,740.16
2016-03-31 62,146.54 2,363.80 4,466.58
2015-03-31 51,784.53 3,399.03 3,606.18
2014-03-31 43,842.21 3,167.45 5,397.63
2013-03-31 37,988.80 3,043.50 4,473.31
2012-03-31 31,475.26 2,193.46 3,751.27

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Apollo Hospitals Enterprise has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Apollo Hospitals Enterprise used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
  • Apollo Hospitals Enterprise's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Apollo Hospitals Enterprise's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Apollo Hospitals Enterprise has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Apollo Hospitals Enterprise's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Apollo Hospitals Enterprise's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Apollo Hospitals Enterprise is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Apollo Hospitals Enterprise's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Apollo Hospitals Enterprise's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Apollo Hospitals Enterprise Company Filings, last reported 10 months ago.

NSEI:APOLLOHOSP Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-03-31 33,839.42 34,310.08 3,642.06
2017-03-31 34,377.77 31,252.92 3,886.27
2016-03-31 34,090.63 28,370.85 4,237.16
2015-03-31 32,443.46 19,922.58 5,229.03
2014-03-31 29,954.63 13,443.58 4,296.48
2013-03-31 27,641.17 11,367.77 6,988.23
2012-03-31 25,193.79 8,166.59 3,588.21
  • Apollo Hospitals Enterprise's level of debt (101.4%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (41.1% vs 101.4% today).
  • Debt is not well covered by operating cash flow (15.7%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 1.8x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Apollo Hospitals Enterprise's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Apollo Hospitals Enterprise has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Apollo Hospitals Enterprise's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.43%
Current annual income from Apollo Hospitals Enterprise dividends. Estimated to be 0.7% next year.
If you bought ₹2,000 of Apollo Hospitals Enterprise shares you are expected to receive ₹9 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Apollo Hospitals Enterprise's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.55%).
  • Apollo Hospitals Enterprise's dividend is below the markets top 25% of dividend payers in India (2.07%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NSEI:APOLLOHOSP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below
India Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 0.7%
India Market Average Dividend Yield Market Cap Weighted Average of 1397 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.6%
India Top 25% Dividend Yield 75th Percentile 2.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NSEI:APOLLOHOSP Future Dividends Estimate Data
Date (Data in ₹) Dividend per Share (annual) Avg. No. Analysts
2023-03-31
2022-03-31
2021-03-31 9.61 10.00
2020-03-31 8.11 13.00
2019-03-31 7.01 14.00
NSEI:APOLLOHOSP Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2018-05-30 5.000 0.447
2017-05-30 6.000 0.532
2016-03-15 6.000 0.468
2015-05-28 5.750 0.422
2014-05-28 5.750 0.498
2013-05-20 5.500 0.604
2012-05-29 4.000 0.538
2011-07-14 3.750 0.661
2011-05-24 3.750 0.774
2010-05-28 3.500 0.782
2009-06-29 3.250 1.066
2009-06-01 3.250 1.258
2009-02-16 3.000 1.489

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Apollo Hospitals Enterprise's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.7x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (4x coverage).
X
Income/ dividend checks
We assess Apollo Hospitals Enterprise's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Apollo Hospitals Enterprise afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Apollo Hospitals Enterprise has a total score of 4/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Apollo Hospitals Enterprise's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Suneeta Reddy
COMPENSATION ₹38,220,000
AGE 59
TENURE AS CEO 4.6 years
CEO Bio

Mrs. Suneeta Reddy has been Managing Director of Apollo Hospitals Enterprise Ltd. since July 2, 2014. Mrs. Reddy served as Joint Managing Director of Apollo Hospitals Enterprise Ltd. since February 3, 2011. She serves as Joint Managing Director of Apollo Sindoori Hotels Limited. She served as Joint Managing Director of the erstwhile Indian Hospitals Corporation Limited. Mrs. Reddy served as an Executive Director of Finance at Apollo Hospitals Enterprise Ltd., from May 2000 to May 31, 2011. She serves as the Chairperson of Aircel Cellular Limited. She served as Chairperson of Cellular Operators Association of India. She served as Chairperson and Director of Aditya Birla Money Limited until March 6, 2009. She serves as a Non-Executive Director of Apollo Sindoori Hotels Limited. She serves as a Director of Apollo Munich Health Insurance Company Limited. She has been a Non-Executive Director of Indraprastha Medical Corp. Ltd. since August 31, 2005. She has been an Executive Director at Apollo Hospitals Enterprise Ltd. since May 1, 2000. She serves as a Non-Executive Director of Apollo Hospitals International Limited, Apollo Sindoori Capital Investments Ltd., Apollo Mumbai Hospitals Limited, PCR Investments Limited, Apollo Health and Lifestyle Limited, Family Health Plan Limited, Apollo Gleneagles Hospital Limited, Ab Medical Centres Limited, Apollo Infrastructure Project Finance Co. Ltd., Samudra Healthcare Enterprises Limited, Imperial Cancer Hospital and Research Centre Limited and Apollo Hospital (UK) Limited. She served as a Director of Apollo Health Street Limited from February 25, 2000 to April 19, 2005. Mrs. Reddy served as a Director of The Lanka Hospitals Corporation Limited. She holds her Bachelor of Arts Degree in Economics and Marketing from the Madras University with a University Rank. She holds a Diploma in Financial Management and has completed the Owner/President Management Program at Harvard Business School, Boston, USA.

CEO Compensation
  • Suneeta's compensation has been consistent with company performance over the past year.
  • Suneeta's remuneration is about average for companies of similar size in India.
Management Team Tenure

Average tenure and age of the Apollo Hospitals Enterprise management team in years:

6.2
Average Tenure
59
Average Age
  • The average tenure for the Apollo Hospitals Enterprise management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Prathap Reddy

TITLE
Founder & Executive Chairman
COMPENSATION
₹96M
AGE
86

Suneeta Reddy

TITLE
MD & Executive Director
COMPENSATION
₹38M
AGE
59
TENURE
4.6 yrs

Sangita Reddy

TITLE
Joint MD & Executive Director
COMPENSATION
₹37M
AGE
56
TENURE
4.6 yrs

P. Reddy

TITLE
Executive Vice-Chairperson
COMPENSATION
₹38M
AGE
60

Shobana Kamineni

TITLE
Executive Vice Chairperson
COMPENSATION
₹39M
AGE
58

Krishnaswami Padmanabhan

TITLE
Group President
COMPENSATION
₹10M
AGE
66

Krishnan Akhileswaran

TITLE
Chief Financial Officer
AGE
43

Sindoori Reddy

TITLE
Vice President of Operations
TENURE
8.3 yrs

G. Reddy

TITLE
Senior General Manager of Finance & Accounts
AGE
63

Binod Samal

TITLE
Chief Technology Officer
COMPENSATION
₹4M
AGE
49
TENURE
7.8 yrs
Board of Directors Tenure

Average tenure and age of the Apollo Hospitals Enterprise board of directors in years:

4.6
Average Tenure
59.5
Average Age
  • The tenure for the Apollo Hospitals Enterprise board of directors is about average.
Board of Directors

Prathap Reddy

TITLE
Founder & Executive Chairman
COMPENSATION
₹96M
AGE
86

Suneeta Reddy

TITLE
MD & Executive Director
COMPENSATION
₹38M
AGE
59
TENURE
18.8 yrs

Sangita Reddy

TITLE
Joint MD & Executive Director
COMPENSATION
₹37M
AGE
56
TENURE
18.6 yrs

P. Reddy

TITLE
Executive Vice-Chairperson
COMPENSATION
₹38M
AGE
60
TENURE
4.6 yrs

Shobana Kamineni

TITLE
Executive Vice Chairperson
COMPENSATION
₹39M
AGE
58
TENURE
4.6 yrs

Ganesan Venkatraman

TITLE
Independent Non-Executive Director
COMPENSATION
₹2M
AGE
74
TENURE
13.2 yrs

Narayanan Vaghul

TITLE
Independent Director
COMPENSATION
₹2M
AGE
82
TENURE
18.3 yrs

Vinayak Chatterjee

TITLE
Independent Director
COMPENSATION
₹2M
AGE
58
TENURE
4.6 yrs

T. Rajgopal

TITLE
Non- Executive Independent Director
COMPENSATION
₹1M
TENURE
1.8 yrs

Murali Doraiswamy

TITLE
Non-Executive Independent Director
TENURE
0.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
15. May 18 Buy Indian Hospitals Corporation Limited Company 10. May 18 10. May 18 10,184 ₹1,031.03 ₹10,500,000
X
Management checks
We assess Apollo Hospitals Enterprise's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Apollo Hospitals Enterprise has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Expensive For A Reason? A Look At The Intrinsic Value

In this article I am going to calculate the intrinsic value of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP). … by taking the expected future cash flows and discounting them to their present value. … discounted cash flows (DCF).

Simply Wall St -

What Kind Of Shareholders Own Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)?

A look at the shareholders of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) can tell us which group is most powerful. … With a market capitalization of ₹180b, Apollo Hospitals Enterprise is a decent size, so it is probably on the radar of institutional investors. … Check out our latest analysis for Apollo Hospitals Enterprise

Simply Wall St -

Should Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Focus On Improving This Fundamental Metric?

To keep the lesson grounded in practicality, we'll use ROE to better understand Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP). … Our data shows Apollo Hospitals Enterprise has a return on equity of 1.8% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

How Financially Strong Is Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)?

Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP), with a market cap of ₹176b, are often out of the spotlight. … Don’t forget that this is a general and concentrated examination of Apollo Hospitals Enterprise’s financial health, so you should conduct further analysis. … See our latest analysis for Apollo Hospitals Enterprise

Simply Wall St -

Is Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Paid Enough Relative To Peers?

This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … How Does Suneeta Reddy's Compensation Compare With Similar Sized Companies. … Our data indicates that Apollo Hospitals Enterprise Limited is worth ₹163b, and total annual CEO compensation is ₹38m.

Simply Wall St -

Estimating The Intrinsic Value Of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)

Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) as an investment opportunity. … by estimating the company's future cash flows and discounting them to their present value. … If you are reading this and its not October 2018 then I highly recommend you check out the latest calculation for Apollo Hospitals Enterprise by following the link below

Simply Wall St -

What Should You Know About Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Return On Capital?

and want to begin learning the link between Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)’s return fundamentals and stock market performance. … Apollo Hospitals Enterprise stock represents an ownership share in the company. … Therefore, looking at how efficiently Apollo Hospitals Enterprise is able to use capital to create earnings will help us understand your potential return.

Simply Wall St -

Who Are The Major Shareholders In Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)?

I am going to take a deep dive into Apollo Hospitals Enterprise Limited’s (NSE:APOLLOHOSP) most recent ownership structure, not a frequent subject of discussion among individual investors. … When it comes to ownership structure of a company, the impact has been observed in both the long-and short-term performance of shares. … See our latest analysis for Apollo Hospitals Enterprise

Simply Wall St -

How Has Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Performed Against The Industry?

When Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) announced its latest earnings (31 March 2018), I wanted to understand how these figures stacked up against its past performance. … The two benchmarks I used were Apollo Hospitals Enterprise's average earnings over the past couple of years, and its industry performance. … Check out our latest analysis for Apollo Hospitals Enterprise?

Simply Wall St -

Are Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Interest Costs Too High?

Mid-caps stocks, like Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) with a market capitalization of ₹145.73b, aren’t the focus of most investors who prefer to direct their investments towards either large-cap or small-cap stocks. … Today we will look at APOLLOHOSP’s financial liquidity and debt levels, which are strong indicators for whether the company can weather economic downturns or fund strategic acquisitions for future growth. … Check out our latest analysis for Apollo Hospitals Enterprise

Simply Wall St -

Company Info

Map
Description

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company’s healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospitals provide care in approximately 55 specialties, including cardiac sciences, oncology, critical care, neurosciences, orthopedics, gastroenterology, and transplants. The company also provides other services, such as project consultancy, health insurance, education and training program, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. As of January 25, 2019, the company operated 71 hospitals with approximately 10,000 beds; 3,000 pharmacies; approximately 90 primary care and diagnostic clinics; and approximately 110 telemedicine centers. Apollo Hospitals Enterprise Limited was founded in 1979 and is headquartered in Chennai, India.

Details
Name: Apollo Hospitals Enterprise Limited
APOLLOHOSP
Exchange: NSEI
Founded: 1979
₹160,320,876,973
139,125,159
Website: http://www.apollohospitals.com
Address: Apollo Hospitals Enterprise Limited
Sunny Side Building,
3rd Floor,
Chennai,
Tamil Nadu, 600006,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NSEI APOLLOHOSP Equity Shares National Stock Exchange of India IN INR 10. Jan 1996
BSE 508869 Equity Shares Mumbai Stock Exchange IN INR 10. Jan 1996
BDL APHOS GDR EACH REPR 1 INR10 'REGS Bourse de Luxembourg LU USD 14. Jul 2005
Number of employees
Current staff
Staff numbers
54,698
Apollo Hospitals Enterprise employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/15 12:52
End of day share price update: 2019/02/14 00:00
Last estimates confirmation: 2019/02/12
Last earnings filing: 2018/09/11
Last earnings reported: 2018/03/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.